Back
Speaker illustration

Doctor Tamas Gergely

Gottsegen National Cardiovascular Center, Budapest (Hungary)

Member of:

European Society of Cardiology
Heart Failure Association of the ESC

Presentations Articles

Obesity paradox in patients with heart failure with reduced ejection fraction across a wide body mass index spectrum: does it still exist in light of contemporary guideline-directed medical therapy?

Event: ESC Congress 2025

Topic: Comorbidities

Session: Assessing risk in heart failure with novel biomarkers

Access
Like
Thumbnail

Myocardial expression of immune checkpoint molecules in patients with advanced heart failure

Event: ESC Cardio-Oncology 2025

Topic: Research and New Technology

Session: Basic and translational cardio-oncology beyond anthracyclines

Access
Like
Thumbnail

Effect of obesity on the implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Novel insights into heart failure therapeutics

Access
Like
Thumbnail

Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Heart Failure

Session: Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

Access
Like
Thumbnail

Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6J mice

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Moderated poster 1 AWARD

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources